Related references
Note: Only part of the references are listed.Interactions between SARS-CoV-2 N-Protein and α-Synuclein Accelerate Amyloid Formation
Slav A. Semerdzhiev et al.
ACS CHEMICAL NEUROSCIENCE (2022)
Comparison of serum neurodegenerative biomarkers among hospitalized COVID-19 patients versus non-COVID subjects with normal cognition, mild cognitive impairment, or Alzheimer's dementia
Jennifer A. Frontera et al.
ALZHEIMERS & DEMENTIA (2022)
SARS-CoV-2 spike S1 subunit induces neuroinflammatory, microglial and behavioral sickness responses: Evidence of PAMP-like properties
Matthew G. Frank et al.
BRAIN BEHAVIOR AND IMMUNITY (2022)
Detection of SARS-CoV-2-RNA in post-mortem samples of human eyes
Josef Penkava et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2022)
Detection of SARS-CoV-2 genomic and subgenomic RNA in retina and optic nerve of patients with COVID-19
Maria Casagrande et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2022)
COVID-19 and neurological disorders: are neurodegenerative or neuroimmunological diseases more vulnerable?
Luigi Ferini-Strambi et al.
JOURNAL OF NEUROLOGY (2021)
Invited Review: The spectrum of neuropathology in COVID-19
S. Al-Sarraj et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2021)
Anosmia in COVID-19: Underlying Mechanisms and Assessment of an Olfactory Route to Brain Infection
Rafal Butowt et al.
NEUROSCIENTIST (2021)
Synaptic basis of Alzheimer's disease: Focus on synaptic amyloid beta, P-tau and mitochondria
Albin John et al.
AGEING RESEARCH REVIEWS (2021)
Neuroinvasion of SARS-CoV-2 in human and mouse brain
Eric Song et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2021)
Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19)
Biyan Nathanael Harapan et al.
JOURNAL OF NEUROLOGY (2021)
Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19
Jenny Meinhardt et al.
NATURE NEUROSCIENCE (2021)
The S1 protein of SARS-CoV-2 crosses the blood-brain barrier in mice
Elizabeth M. Rhea et al.
NATURE NEUROSCIENCE (2021)
SARS-CoV-2 Exacerbates Beta-Amyloid Neurotoxicity, Inflammation and Oxidative Stress in Alzheimer's Disease Patients
Luigi Chiricosta et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Parkinson's Disease and the COVID-19 Pandemic
Conor Fearon et al.
JOURNAL OF PARKINSONS DISEASE (2021)
COVID-19 Case Fatality and Alzheimer's Disease
Qiang Zhang et al.
JOURNAL OF ALZHEIMERS DISEASE (2021)
Prophylactic intranasal administration of a TLR2/6 agonist reduces upper respiratory tract viral shedding in a SARS-CoV-2 challenge ferret model
Pamela C. Proud et al.
EBIOMEDICINE (2021)
COVID-19 and dementia: Analyses of risk, disparity, and outcomes from electronic health records in the US
QuanQiu Wang et al.
ALZHEIMERS & DEMENTIA (2021)
Effects of innate immune receptor stimulation on extracellular α-synuclein uptake and degradation by brain resident cells
Changyoun Kim et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2021)
Interactions of SARS-CoV-2 with the Blood-Brain Barrier
Michelle A. Erickson et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Role of Toll-like receptors in the pathogenesis of COVID-19
Shaghayegh Khanmohammadi et al.
JOURNAL OF MEDICAL VIROLOGY (2021)
Reactive microglia enhance the transmission of exosomal α-synuclein via toll-like receptor 2
Yun Xia et al.
BRAIN (2021)
Can SARS-CoV-2 Infection Lead to Neurodegeneration and Parkinson's Disease?
Lea Krey et al.
BRAIN SCIENCES (2021)
Nervous System Involvement in COVID-19: a Review of the Current Knowledge
Mahnaz Norouzi et al.
MOLECULAR NEUROBIOLOGY (2021)
TLR2 senses the SARS-CoV-2 envelope protein to produce inflammatory cytokines
Min Zheng et al.
NATURE IMMUNOLOGY (2021)
SARS-CoV-2 and the brain: A review of the current knowledge on neuropathology in COVID-19
Aniello Maiese et al.
BRAIN PATHOLOGY (2021)
Deep spatial profiling of human COVID-19 brains reveals neuroinflammation with distinct microanatomical microglia-T-cell interactions
Marius Schwabenland et al.
IMMUNITY (2021)
Direct Activation of Endothelial Cells by SARS-CoV-2 Nucleocapsid Protein Is Blocked by Simvastatin
Yisong Qian et al.
JOURNAL OF VIROLOGY (2021)
Effects of the Coronavirus Disease 2019 Pandemic on Motor Symptoms in Parkinson's Disease: An Observational Study
Mitsuhiro Kainaga et al.
MOVEMENT DISORDERS (2021)
Network medicine links SARS-CoV-2/COVID-19 infection to brain microvascular injury and neuroinflammation in dementia-like cognitive impairment
Yadi Zhou et al.
ALZHEIMERS RESEARCH & THERAPY (2021)
SARS-CoV-2: is there neuroinvasion?
Conor McQuaid et al.
FLUIDS AND BARRIERS OF THE CNS (2021)
The Influence of Coronavirus Disease-2019 (COVID-19) On Parkinson's Disease: An Updated Systematic Review
Vikash Jaiswal et al.
JOURNAL OF PRIMARY CARE AND COMMUNITY HEALTH (2021)
Atlas of ACE2 gene expression reveals novel insights into transmission of SARS-CoV-2
Kun Sun et al.
HELIYON (2021)
Ubiquity of the SARS-CoV-2 receptor ACE2 and upregulation in limbic regions of Alzheimer's disease brain
Yuhai Zhao et al.
FOLIA NEUROPATHOLOGICA (2021)
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China
Dawei Wang et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Anticipating and Mitigating the Impact of the COVID-19 Pandemic on Alzheimer's Disease and Related Dementias
Eric E. Brown et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2020)
A first case of meningitis/encephalitis associated with SARS-Coronavirus-2
Takeshi Moriguchi et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)
The Impact of the COVID-19 Pandemic on Parkinson?s Disease: Hidden Sorrows and Emerging Opportunities
Rick C. Helmich et al.
JOURNAL OF PARKINSONS DISEASE (2020)
Modeling Parkinson's Disease With the Alpha-Synuclein Protein
Monica Gomez-Benito et al.
FRONTIERS IN PHARMACOLOGY (2020)
Encephalitis Associated with COVID-19 Infection in an 11-Year-Old Child
Gary N. McAbee et al.
PEDIATRIC NEUROLOGY (2020)
The Effects of Confinement on Neuropsychiatric Symptoms in Alzheimer's Disease During the COVID-19 Crisis
Claire Boutoleau-Bretonniere et al.
JOURNAL OF ALZHEIMERS DISEASE (2020)
Neuropathological Features of Covid-19
Isaac H. Solomon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Decreased T cell populations contribute to the increased severity of COVID-19
Rui Liu et al.
CLINICA CHIMICA ACTA (2020)
Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy
Corrado Lodigiani et al.
THROMBOSIS RESEARCH (2020)
Immediate and long-term consequences of COVID-19 infections for the development of neurological disease
Michael T. Heneka et al.
ALZHEIMERS RESEARCH & THERAPY (2020)
How SARS-Cov-2 can involve the central nervous system. A systematic analysis of literature of the department of human neurosciences of Sapienza University, Italy
Daniele Armocida et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2020)
Elevation of ACE2 as a SARS-CoV-2 entry receptor gene expression in Alzheimer's disease
Key-Hwan Lim et al.
JOURNAL OF INFECTION (2020)
LRRK2 mediates microglial neurotoxicity via NFATc2 in rodent models of synucleinopathies
Changyoun Kim et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Commentary: APOE e4 Genotype Predicts Severe COVID-19 in the UK Biobank Community Cohort
Kyle Kasparian et al.
FRONTIERS IN IMMUNOLOGY (2020)
Anti-SARS-CoV-2 antibodies in the CSF, blood-brain barrier dysfunction, and neurological outcome
Harry Alexopoulos et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2020)
The novel coronavirus Disease-2019 (COVID-19): Mechanism of action, detection and recent therapeutic strategies
Elahe Seyed Hosseini et al.
VIROLOGY (2020)
Neuropathobiology of COVID-19: The Role for Glia
Marie-Eve Tremblay et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2020)
COVID-19, immune system response, hyperinflammation and repurposing antirheumatic drugs
Abdurrahman Tufan et al.
TURKISH JOURNAL OF MEDICAL SCIENCES (2020)
ApoE4: an emerging therapeutic target for Alzheimer's disease
Mirna Safieh et al.
BMC MEDICINE (2019)
Racial and ethnic estimates of Alzheimer's disease and related dementias in the United States (2015-2060) in adults aged >= 65 years
Kevin A. Matthews et al.
ALZHEIMERS & DEMENTIA (2019)
Targeting Microglial and Neuronal Toll-like Receptor 2 in Synucleinopathies
Somin Kwon et al.
EXPERIMENTAL NEUROBIOLOGY (2019)
Alpha-synuclein oligomers impair memory through glial cell activation and via Toll-like receptor 2
Pietro La Vitola et al.
BRAIN BEHAVIOR AND IMMUNITY (2018)
Early minor stimulation of microglial TLR2 and TLR4 receptors attenuates Alzheimer's disease-related cognitive deficit in rats: behavioral, molecular, and electrophysiological evidence
Hamid Gholami Pourbadie et al.
NEUROBIOLOGY OF AGING (2018)
Toll-Like Receptor 2 Signaling and Current Approaches for Therapeutic Modulation in Synucleinopathies
Ian F. Caplan et al.
FRONTIERS IN PHARMACOLOGY (2018)
Selective disruption of TLR2-MyD88 interaction inhibits inflammation and attenuates Alzheimer's pathology
Suresh B. Rangasamy et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Immunotherapy targeting toll-like receptor 2 alleviates neurodegeneration in models of synucleinopathy by modulating α-synuclein transmission and neuroinflammation
Changyoun Kim et al.
MOLECULAR NEURODEGENERATION (2018)
Mobilizing Parkinson's Disease: The Future of Exercise
Terry Ellis et al.
JOURNAL OF PARKINSONS DISEASE (2018)
Prevalence of Parkinson's disease across North America
C. Marras et al.
NPJ PARKINSONS DISEASE (2018)
Toll-like receptor 2 is increased in neurons in Parkinson's disease brain and may contribute to alpha-synuclein pathology
Nicolas Dzamko et al.
ACTA NEUROPATHOLOGICA (2017)
TREADMILL EXERCISE PRODUCES NEUROPROTECTIVE EFFECTS IN A MURINE MODEL OF PARKINSON'S DISEASE BY REGULATING THE TLR2/MYD88/NF-κB SIGNALING PATHWAY
Jung-Hoon Koo et al.
NEUROSCIENCE (2017)
Single nucleotide polymorphisms in the toll-like receptor 2 (TLR2) gene are associated with sporadic Parkinson's disease in the North-eastern Han Chinese population
Xiaoyuan Li et al.
NEUROSCIENCE LETTERS (2017)
Parkinson disease
Werner Poewe et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
The blood-brain barrier in systemic inflammation
Aravinthan Varatharaj et al.
BRAIN BEHAVIOR AND IMMUNITY (2017)
Genetic Factors Affecting Late-Onset Alzheimer's Disease Susceptibility
Maryam Rezazadeh et al.
NEUROMOLECULAR MEDICINE (2016)
Inhibiting TLR2 activation attenuates amyloid accumulation and glial activation in a mouse model of Alzheimer's disease
Claire L. McDonald et al.
BRAIN BEHAVIOR AND IMMUNITY (2016)
Toll-like receptors mediating vascular malfunction: Lessons from receptor subtypes
Yu Wang et al.
PHARMACOLOGY & THERAPEUTICS (2016)
Angiotensin-converting enzyme 2 is reduced in Alzheimer's disease in association with increasing amyloid-β and tau pathology
Patrick Gavin Kehoe et al.
ALZHEIMERS RESEARCH & THERAPY (2016)
Non-cell-autonomous Neurotoxicity of α-synuclein Through Microglial Toll-like Receptor 2
Changyoun Kim et al.
EXPERIMENTAL NEUROBIOLOGY (2016)
Elevated neuronal α-synuclein promotes microglia activation after spinal cord ischemic/reperfused injury
Hongfei Qiao et al.
NEUROREPORT (2015)
Activation of MyD88-dependent TLR1/2 signaling by misfolded α-synuclein, a protein linked to neurodegenerative disorders
Stefano G. Daniele et al.
SCIENCE SIGNALING (2015)
Antagonizing Neuronal Toll-like Receptor 2 Prevents Synucleinopathy by Activating Autophagy
Changyoun Kim et al.
CELL REPORTS (2015)
Activation of MyD88-dependent TLR1/2 signaling by misfolded α-synuclein, a protein linked to neurodegenerative disorders
Stefano G. Daniele et al.
SCIENCE SIGNALING (2015)
Toll-Like Receptor Expression in the Blood and Brain of Patients and a Mouse Model of Parkinson's Disease
Janelle Drouin-Ouellet et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2015)
TLR2 mediates phagocytosis and autophagy through JNK signaling pathway in Staphylococcus aureus-stimulated RAW264.7 cells
Lei Fang et al.
CELLULAR SIGNALLING (2014)
Innate immune responses regulate morphogenesis and degeneration: roles of Toll-like receptors and Sarm1 in neurons
Hsin-Yu Liu et al.
NEUROSCIENCE BULLETIN (2014)
Toll-like receptor signaling pathways
Takumi Kawasaki et al.
FRONTIERS IN IMMUNOLOGY (2014)
TLR9 -1237 T/C and TLR2 -194 to -174 del polymorphisms and the risk of Parkinson's disease in the Greek population: a pilot study
Kallirhoe Kalinderi et al.
NEUROLOGICAL SCIENCES (2013)
The Herpes Simplex Virus 1-Encoded Envelope Glycoprotein B Activates NF-κB through the Toll-Like Receptor 2 and MyD88/TRAF6-Dependent Signaling Pathway
Mingsheng Cai et al.
PLOS ONE (2013)
Preconditioning of Microglia by α-Synuclein Strongly Affects the Response Induced by Toll-like Receptor (TLR) Stimulation
Cintia Roodveldt et al.
PLOS ONE (2013)
TLR2 Is a Primary Receptor for Alzheimer's Amyloid β Peptide To Trigger Neuroinflammatory Activation
Shirong Liu et al.
JOURNAL OF IMMUNOLOGY (2012)
α-Synuclein in Parkinson's Disease
Leonidas Stefanis
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
The role of TLR2 in infect on and immunity
Laura Oliveira-Nascimento et al.
FRONTIERS IN IMMUNOLOGY (2012)
The Structural Biology of Toll-like Receptors
Istvan Botos et al.
STRUCTURE (2011)
Toll-like receptor signaling in neural plasticity and disease
Eitan Okun et al.
TRENDS IN NEUROSCIENCES (2011)
Active Immunization with Amyloid-β 1-42 Impairs Memory Performance through TLR2/4-Dependent Activation of the Innate Immune System
Patrick Vollmar et al.
JOURNAL OF IMMUNOLOGY (2010)
DAMPening Inflammation by Modulating TLR Signalling
A. M. Piccinini et al.
MEDIATORS OF INFLAMMATION (2010)
CD14 and Toll-Like Receptors 2 and 4 Are Required for Fibrillar Aβ-Stimulated Microglial Activation
Erin G. Reed-Geaghan et al.
JOURNAL OF NEUROSCIENCE (2009)
Differential regulation of toll-like receptor mRNAs in amyloid plaque-associated brain tissue of aged APP23 transgenic mice
Stefanie Frank et al.
NEUROSCIENCE LETTERS (2009)
SARS coronavirus spike protein-induced innate immune response occurs via activation of the NF-κB pathway in human monocyte macrophages in vitro
Susan F. Dosch et al.
VIRUS RESEARCH (2009)
Structures of the toll-like receptor family and its ligand complexes
Mi Sun Jin et al.
IMMUNITY (2008)
Fibrillar Amyloid-β Peptides Activate Microglia via TLR2: Implications for Alzheimer's Disease
Malabendu Jana et al.
JOURNAL OF IMMUNOLOGY (2008)
Toll-like receptor 2 acts as a natural innate immune receptor to clear amyloid β1-42 and delay the cognitive decline in a mouse model of Alzheimer's disease
Karine L. Richard et al.
JOURNAL OF NEUROSCIENCE (2008)
Up-regulation of IL-6 and TNF-α induced by SARS-coronavirus spike protein in murine macrophages via NF-κB pathway
Wei Wang et al.
VIRUS RESEARCH (2007)
Activation of toll-like receptor 2 on microglia promotes cell uptake of Alzheimer disease-associated amyloid β peptide
KQ Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Varicella-zoster virus activates inflammatory cytokines in human monocytes and macrophages via Toll-like receptor 2
JP Wang et al.
JOURNAL OF VIROLOGY (2005)
A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2
SK Wong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)